You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API ZANUBRUTINIB

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing ZANUBRUTINIB

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
BEIGENE USA INC	BRUKINSA	zanubrutinib	72579-011	CELLULOSE, MICROCRYSTALLINE	2037-08-15
BEIGENE USA INC	BRUKINSA	zanubrutinib	72579-011	CROSCARMELLOSE SODIUM	2037-08-15
BEIGENE USA INC	BRUKINSA	zanubrutinib	72579-011	FERROSOFERRIC OXIDE	2037-08-15
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for ZANUBRUTINIB

Excipient focus: CELLULOSE, MICROCRYSTALLINE

ZANUBRUTINIB drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
BEIGENE USA INC	zanubrutinib	72579-011
>Company	>Ingredient	>NDC

ZANUBRUTINIB drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

ZANUBRUTINIB drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
BEIGENE USA INC	zanubrutinib	72579-011
>Company	>Ingredient	>NDC

ZANUBRUTINIB drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERROSOFERRIC OXIDE

ZANUBRUTINIB drug variants containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
BEIGENE USA INC	zanubrutinib	72579-011
>Company	>Ingredient	>NDC

ZANUBRUTINIB drug variants not containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GELATIN

ZANUBRUTINIB drug variants containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
BEIGENE USA INC	zanubrutinib	72579-011
>Company	>Ingredient	>NDC

ZANUBRUTINIB drug variants not containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

ZANUBRUTINIB drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
BEIGENE USA INC	zanubrutinib	72579-011
>Company	>Ingredient	>NDC

ZANUBRUTINIB drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

ZANUBRUTINIB drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
BEIGENE USA INC	zanubrutinib	72579-011
>Company	>Ingredient	>NDC

ZANUBRUTINIB drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM LAURYL SULFATE

ZANUBRUTINIB drug variants containing SODIUM LAURYL SULFATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
BEIGENE USA INC	zanubrutinib	72579-011
>Company	>Ingredient	>NDC

ZANUBRUTINIB drug variants not containing SODIUM LAURYL SULFATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

ZANUBRUTINIB drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
BEIGENE USA INC	zanubrutinib	72579-011
>Company	>Ingredient	>NDC

ZANUBRUTINIB drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.